Please login to the form below

Not currently logged in

The Langland Award for Excellence in Healthcare Partnerships

Sponsored by

Back to results


The London Testing Alliance

by OVID Health for MedCity

Summary of work

OVID Health and MedCity collaborated with leading London health science academic institutions to deliver a minimum of 20,500 additional daily tests to the COVID-19 national testing programme. At the time of its launch, this constituted a 9% uplift in the total number of daily tests in the UK.
The London Testing Alliance was formed in April 2020 to leverage the capabilities at Imperial College London, King’s Health Partners, UCL with Health Services Laboratories and Queen Mary’s University London. This included lab space, expert knowledge and connectivity with NHS data systems to bring online new COVID-19 testing capacity as part of the national effort.
At its launch, Health Secretary Matt Hancock thanked the Alliance for being part of the national collective effort, describing the London Testing Alliance as “invaluable for increasing testing capacity at this crucial time.”
OVID Health’s objective was first and foremost to explain the offer to the key decision-makers and bring them to the table at a time of unprecedented demand on them. Our second objective was to raise the profile of MedCity with key stakeholders as the convener of choice across London to deliver rapid health benefits for the public during the pandemic at scale and pace.

Judges' comments

Situational analysis was clear in this entry and the team demonstrated a true need for the partnerships established. The programme implementation was equally remarkable, with many partnerships formed, demonstrating a true working relationship that focused on a common goal to deliver impressive outcomes. It was also good to see the strong feedback from stakeholders.


ACTION ON FISTULA™ – Changing the Fistula Treatment Landscape in Kenya - by Astellas Pharma Europe Ltd and Fistula Foundation

Highly commended

New Normal Same Cancer – Reversing the COVID-19 Effect on Cancer Care - by MHP Communications for AstraZeneca Global


Helping Head and Neck cancer survivors overcome barriers to employment - by Aurora Healthcare Communications for Bristol Myers Squibb

I Am Number 17 - Raising Awareness of Rare Disease Across the UK - by Hill+Knowlton Strategies for Takeda

The London Testing Alliance - by OVID Health for MedCity

Category Sponsors

Key dates

Entry deadline 10th March 2023
Extended entry deadline 17th March 2023
(additional fee applies)
Judging days 4th, 5th and 19th
May 2023
Awards Ceremony 6th July 2023

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243

Entry and dinner booking enquiries:
Charlotte Garnade
Tel: 01372 414253